促进低剂量CT肺癌筛查共享决策的工具:系统综述
工具可改善患者对筛查的知识并降低决策冲突,患者和医生接受度较高,但低剂量CT完成率研究间存在差异。
要点
- 现有共享决策工具可改善患者对肺癌筛查的知识并降低决策冲突。
- 工具在患者和医生中接受度较高,但低剂量CT完成率研究间不一致。
- 需采用统一测量和报告方法进一步评估工具的比较效果与实施可行性。
核心结论
- 14项研究的证据提示,现有肺癌筛查工具的部分要素可通过改善知识和降低决策冲突来帮助患者做好准备。
- 此类工具通常为患者和提供者所接受,但仍需统一测量和报告方法的研究来确定比较效果与实施可行性。
研究设计与样本
- 筛查2427条记录后纳入1项随机对照试验、2项观察性研究和11项决策辅助或教育工具的前后研究。
主要发现
- 9项研究报告患者肺癌筛查知识改善,但特定知识领域的改善不一致。
- 7项研究报告使用工具后决策冲突低或降低。
- 7项研究报告患者对工具的可接受性评为「高」,1项研究报告医生评为「高」。
- 6项研究报告低剂量CT完成率,但研究间存在差异。
临床怎么用
- 可考虑使用现有共享决策工具帮助患者了解肺癌筛查的风险与获益并参与决策。
- 使用工具时需注意知识改善和决策冲突降低的证据不一致,低剂量CT完成率数据有限。
局限性
- 多数纳入研究质量一般。
- 知识改善在特定领域不一致,低剂量CT完成率研究间存在差异。
- 缺乏统一的测量和报告方法,相关决策和临床结局评估不足。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Decisions about lung cancer screening are inherently complex and create a need for methods to convey the risks and benefits of screening to patients. RESEARCH QUESTION: What kind of decision aids or tools are available to support shared decision-making for lung cancer screening? What is the current evidence for the effectiveness, acceptability, and feasibility of those tools? STUDY DESIGN AND METHODS: We conducted a systematic review of studies and searched PubMed, MEDLINE, EMBASE, Cochrane Clinical Trials Register, and ClinicalTrials.gov from inception to December 2019 for studies that evaluated the effectiveness and acceptability of tools to promote shared decision-making for patients who are considering lung cancer screening. RESULTS: After screening 2,427 records, we included one randomized control trial, two observational studies, 11 before/after studies of a decision aid or an educational tool. Fifteen distinct tools in various formats were evaluated in 14 studies. Most studies were of fair quality. Studies reported improvement in patients' knowledge of lung cancer screening (n = 9 studies), but improvements in specific areas of knowledge were inconsistent. Decisional conflict was low or reduced after the administration of the tools (n = 7 studies). The acceptability of tools was rated as "high" by patients (n = 7 studies) and physicians (n = 1 study). Low dose CT scan completion rates varied among studies (n = 6 studies). INTERPRETATION: Evidence from 14 studies suggests that some elements of existing tools for lung cancer screening may help to prepare patients for decision-making by improving knowledge and reducing decisional conflict. Such tools generally are acceptable to patients and providers. Further studies that use consistent measures and reporting methods and assess relevant decisional and clinical outcomes are needed to determine the comparative effectiveness and feasibility of implementation of these tools. CLINICAL TRIAL REGISTRATION: PROSPERO 2018 CRD4201874814.
引用
- Fukunaga MI, Halligan K, Kodela J, et al. Tools to Promote Shared Decision-Making in Lung Cancer Screening Using Low-Dose CT Scanning: A Systematic Review. Chest. 2020. PMID: 32629037. doi:10.1016/j.chest.2020.05.610
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。